Targeted small molecule therapy in oncology

You are here: Home Programme Scientific Programme Programme Targeted small molecule therapy in oncology

Monday 14 July 2014 13:30 – 15:00
Track 4 - Targeted small molecule therapy in oncology

Chair: Thomas Witzig

Targeting the mTOR pathway in hematological malignancies
Thomas Witzig

Targeting JAK2 and ABL in myeloid malignancies
Animesh Pardanani

Immunomodulatory derivatives (IMIDs)
Grzegorz Nowakowski

South African Society for Basic and Clinical Pharmacology Section 21 Company, Registration no. 2006/029963/08 Registry Office: Alchemy Financial Services Unit 3 Bush Hill Office Park, Jan Frederick Ave, Honeydew 2154

Monday 14 July 2014 13:30 – 15:00 Track 4 - Targeted small molecule therapy in oncology

Chair: Thomas Witzig

Monday 14 July 2014 13:30 – 15:00
Track 4 - Targeted small molecule therapy in oncology